New research shows white blood cells activated by COVID-19 may have cancer-fighting abilities, offering hope for future ...

Researchers discovered that severe COVID infection causes the body to produce a special type of monocyte with anti-cancer ...

According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for ...

TCR immunotherapy is emerging as a promising, targeted approach for treating solid tumours and other indications.

The most comprehensive map of the developing human thymus sheds light on how immune responses are built and maintained at early life, with implications for understanding and treating immunodeficiency, ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the ...

The researchers developed in tests using mice a method to stimulate weakened immune activity by restraining the cells restraining the immune response.

Researchers found a molecule that can both help the intestines to heal after damage and suppress tumour growth in colorectal cancer. The discovery could lead to new treatments for inflammatory bowel ...

Scientists have worked out a way of predicting how long a prostate cancer patient will continue to respond to the PARP ...

At OHSU Knight Cancer Institute, patients are front of mind in drive toward cancer early detection, interventions Yujia Zhang ...

A new study from scientists at the UCLA Health Jonsson Comprehensive Cancer Center helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and ...

“We found that the probability of being alive and free of disease at two years was approximately 64% for cetuximab versus 51% ...